Empagliflozin in Patients with Chronic Kidney Disease
Among a wide range of patients with chronic kidney disease who were at risk for disease progression, empagliflozin therapy led to a lower risk of progression of kidney disease o...
Publications
2 shownCardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Glucagon-like peptide-1 (GLP-1) receptor agonists differ in their structure and duration of action and have been studied in trials of varying sizes and with different patient po...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 3,430
- Institution
- Chinese Academy of Medical Sciences & Peking Union Medical College
External Links
Identifiers
- ORCID
- 0000-0003-3139-1836
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.